AstraZeneca PLC (AZN)

Growth

Revenue 5Y7.73%
Revenue 3Y14.81%
EPS 5Y-50.89%
EPS 3Y-64.06%
Dividend 5Y-0.69%
Dividend 3Y-0.37%

Capital Efficiency

ROIC0.23%
ROE0.07%
ROA0.03%
ROTA0.05%

Capital Structure

Market Cap201.35B
EV226.19B
Cash4.46B
Current Ratio0.81
Debt/Equity0.63
Net Debt/EBITDA3.19
Show More

Ratios

Select a metric from the list below to chart it

Dec '02
Dec '06
Dec '10
Dec '14
Dec '18
TTM
Ratios
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Price to Book Ratio
3.5
4.6
4.4
4.6
6.1
7.3
9.7
8.5
4.3
5.6
Price to Book Ratio % Chg.
30.5%
32.3%
-3.6%
4.7%
31.1%
20.8%
33.2%
-12.7%
-49.6%
30.3%
Price to Earnings Ratio
31.4
72.7
28.8
19.6
30.2
42.3
95.7
41.5
1,501.6
7,259.5
Price to Earnings Ratio % Chg.
214.5%
131.8%
-60.3%
-32.1%
54.0%
40.1%
126.3%
-56.6%
3514.4%
383.5%
Price to Free Cash Flow Ratio
15.0
20.8
152.0
37.4
46.2
73.1
250.9
60.5
44.7
30.4
Price to Free Cash Flow Ratio % Chg.
-44.3%
38.7%
629.9%
-75.4%
23.5%
58.0%
243.5%
-75.9%
-26.2%
-32.0%
Price to Operating Cash Flow Ratio
10.8
12.7
24.5
16.5
25.3
34.8
43.0
27.7
28.2
21.1
Price to Operating Cash Flow Ratio % Chg.
19.9%
17.2%
92.9%
-32.5%
53.0%
37.5%
23.6%
-35.7%
1.9%
-25.3%
Price Earnings to Growth Ratio
-0.5
-1.4
0.2
0.8
-2.1
-1.5
-2.4
0.3
-15.5
-1.0
Price Earnings to Growth Ratio % Chg.
69.8%
163.7%
-
257.8%
-
28.4%
62.4%
-
-
93.4%
Price to Sales Ratio
3.1
3.4
3.3
3.0
4.0
4.1
5.2
5.0
4.5
4.4
Price to Sales Ratio % Chg.
38.9%
10.2%
-4.0%
-9.6%
35.2%
2.3%
27.0%
-4.8%
-9.9%
-1.4%
EV to EBITDA
9.8
17.2
13.0
10.9
15.6
14.6
20.6
17.3
25.6
28.4
EV to EBITDA % Chg.
66.6%
75.5%
-24.4%
-16.0%
42.5%
-6.1%
41.1%
-16.0%
47.5%
11.1%